FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2421551738> ?p ?o ?g. }

• W2421551738 endingPage "288" @default.
• W2421551738 startingPage "282" @default.
• W2421551738 abstract "Recombinant human growth hormone (rhGH) is increasingly used in the clinic because it promotes the synthesis of proteins. However, rhGH is able to increase malignant transformation and tumor recurrence. The aim of this study was to investigate the effects of rhGH on hepatocellular carcinoma (HCC) cells with positive and negative growth hormone receptors (GHR) in order to guide its clinical application.Cells of the human HCC cell lines Bel-7402 (GHR+) and SMMC-7721 (GHR-) as well as human umbilical vein endothelial cell line ECV304 cells in the exponential growth phase were harvested and divided into experimental and control groups. After the human HCC cells were cultured alone or co-cultured with ECV304 cells under the different treatments, cell cycle phase, proliferation index, and expression levels of vascular endothelial growth factor (VEGF) mRNA and proteins were determined.In the Bel-7402 GHR+ cells treated with rhGH, both the percentage of cell in G2-M phase and the proliferation index were higher than those of controls (P < 0.05); this was not the case in the SMMC-7721 GHR- cells treated with rhGH (P > 0.05). Although there was no difference in the cell doubling times between ECV304 cells co-incubated with Bel-7721 GHR-cells treated with rhGH and without rhGH, the doubling times of ECV304 cells co-incubated with Bel-7402 GHR+ cells, when treated with rhGH, were significantly shortened compared to those of controls (P < 0.05). The cell doubling times of ECV304 cells co-incubated with Bel-7721 GHR- or Bel-7402 GHR+ cells which were treated with bevacizumab were longer than those of controls and of cells with rhGH (P < 0.05). The VEGF mRNA and protein expression levels were higher in Bel-7402 GHR+ cells treated with different doses of rhGH than controls (P < 0.05 or P < 0.01); however, there was no statistically significant difference in the expression levels of VEGF mRNA and proteins between SMMC-7721 GHR- cells treated with rhGH and controls.rhGH can induce VEGF secretion and stimulate proliferation of Bel-7402 GHR+ cells in vitro, but has little effect on the proliferation of SMMC-7721 GHR-cells, suggesting that rhGH may be applied safely to treatment for the catabolic state in patients with GHR-negative HCC." @default.
• W2421551738 created "2016-06-24" @default.
• W2421551738 creator A5017615574 @default.
• W2421551738 creator A5039935749 @default.
• W2421551738 creator A5042738110 @default.
• W2421551738 creator A5056321641 @default.
• W2421551738 creator A5078321548 @default.
• W2421551738 date "2010-03-01" @default.
• W2421551738 modified "2023-09-27" @default.
• W2421551738 title "Influence of Recombinant Human Growth Hormone (rhGH) on Proliferation of Hepatocellular Carcinoma Cells with Positive and Negative Growth Hormone Receptorsin Vitro" @default.
• W2421551738 cites W1488415233 @default.
• W2421551738 cites W1979361361 @default.
• W2421551738 cites W1983345493 @default.
• W2421551738 cites W1992154099 @default.
• W2421551738 cites W1999053969 @default.
• W2421551738 cites W2000463365 @default.
• W2421551738 cites W2031484405 @default.
• W2421551738 cites W2041229746 @default.
• W2421551738 cites W2053785665 @default.
• W2421551738 cites W2074849180 @default.
• W2421551738 cites W2083328061 @default.
• W2421551738 cites W2098670099 @default.
• W2421551738 cites W2100194109 @default.
• W2421551738 cites W2114256596 @default.
• W2421551738 cites W2125153669 @default.
• W2421551738 cites W2131688013 @default.
• W2421551738 cites W2152697120 @default.
• W2421551738 cites W2157560932 @default.
• W2421551738 cites W2166973314 @default.
• W2421551738 cites W2414785078 @default.
• W2421551738 doi "https://doi.org/10.1177/030089161009600216" @default.
• W2421551738 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20572587" @default.
• W2421551738 hasPublicationYear "2010" @default.
• W2421551738 type Work @default.
• W2421551738 sameAs 2421551738 @default.
• W2421551738 citedByCount "9" @default.
• W2421551738 countsByYear W24215517382014 @default.
• W2421551738 countsByYear W24215517382015 @default.
• W2421551738 countsByYear W24215517382016 @default.
• W2421551738 countsByYear W24215517382017 @default.
• W2421551738 countsByYear W24215517382019 @default.
• W2421551738 countsByYear W24215517382022 @default.
• W2421551738 crossrefType "journal-article" @default.
• W2421551738 hasAuthorship W2421551738A5017615574 @default.
• W2421551738 hasAuthorship W2421551738A5039935749 @default.
• W2421551738 hasAuthorship W2421551738A5042738110 @default.
• W2421551738 hasAuthorship W2421551738A5056321641 @default.
• W2421551738 hasAuthorship W2421551738A5078321548 @default.
• W2421551738 hasConcept C113675107 @default.
• W2421551738 hasConcept C121608353 @default.
• W2421551738 hasConcept C126322002 @default.
• W2421551738 hasConcept C134018914 @default.
• W2421551738 hasConcept C1491633281 @default.
• W2421551738 hasConcept C170493617 @default.
• W2421551738 hasConcept C202751555 @default.
• W2421551738 hasConcept C2777411675 @default.
• W2421551738 hasConcept C29537977 @default.
• W2421551738 hasConcept C2984496839 @default.
• W2421551738 hasConcept C48900799 @default.
• W2421551738 hasConcept C502942594 @default.
• W2421551738 hasConcept C54355233 @default.
• W2421551738 hasConcept C55493867 @default.
• W2421551738 hasConcept C62112901 @default.
• W2421551738 hasConcept C71315377 @default.
• W2421551738 hasConcept C71924100 @default.
• W2421551738 hasConcept C81885089 @default.
• W2421551738 hasConcept C86803240 @default.
• W2421551738 hasConceptScore W2421551738C113675107 @default.
• W2421551738 hasConceptScore W2421551738C121608353 @default.
• W2421551738 hasConceptScore W2421551738C126322002 @default.
• W2421551738 hasConceptScore W2421551738C134018914 @default.
• W2421551738 hasConceptScore W2421551738C1491633281 @default.
• W2421551738 hasConceptScore W2421551738C170493617 @default.
• W2421551738 hasConceptScore W2421551738C202751555 @default.
• W2421551738 hasConceptScore W2421551738C2777411675 @default.
• W2421551738 hasConceptScore W2421551738C29537977 @default.
• W2421551738 hasConceptScore W2421551738C2984496839 @default.
• W2421551738 hasConceptScore W2421551738C48900799 @default.
• W2421551738 hasConceptScore W2421551738C502942594 @default.
• W2421551738 hasConceptScore W2421551738C54355233 @default.
• W2421551738 hasConceptScore W2421551738C55493867 @default.
• W2421551738 hasConceptScore W2421551738C62112901 @default.
• W2421551738 hasConceptScore W2421551738C71315377 @default.
• W2421551738 hasConceptScore W2421551738C71924100 @default.
• W2421551738 hasConceptScore W2421551738C81885089 @default.
• W2421551738 hasConceptScore W2421551738C86803240 @default.
• W2421551738 hasIssue "2" @default.
• W2421551738 hasLocation W24215517381 @default.
• W2421551738 hasLocation W24215517382 @default.
• W2421551738 hasOpenAccess W2421551738 @default.
• W2421551738 hasPrimaryLocation W24215517381 @default.
• W2421551738 hasRelatedWork W1994202936 @default.
• W2421551738 hasRelatedWork W2066519212 @default.
• W2421551738 hasRelatedWork W2072481810 @default.
• W2421551738 hasRelatedWork W2325955194 @default.
• W2421551738 hasRelatedWork W2363880822 @default.
• W2421551738 hasRelatedWork W2373495330 @default.
• W2421551738 hasRelatedWork W2374592133 @default.

• next